167 related articles for article (PubMed ID: 10978722)
1. Normal cellular levels of synaptophysin mRNA expression in the prefrontal cortex of subjects with schizophrenia.
Glantz LA; Austin MC; Lewis DA
Biol Psychiatry; 2000 Sep; 48(5):389-97. PubMed ID: 10978722
[TBL] [Abstract][Full Text] [Related]
2. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain.
Weickert CS; Straub RE; McClintock BW; Matsumoto M; Hashimoto R; Hyde TM; Herman MM; Weinberger DR; Kleinman JE
Arch Gen Psychiatry; 2004 Jun; 61(6):544-55. PubMed ID: 15184234
[TBL] [Abstract][Full Text] [Related]
3. GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons.
Volk D; Austin M; Pierri J; Sampson A; Lewis D
Am J Psychiatry; 2001 Feb; 158(2):256-65. PubMed ID: 11156808
[TBL] [Abstract][Full Text] [Related]
4. Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for 'hypofrontality'.
Karson CN; Mrak RE; Schluterman KO; Sturner WQ; Sheng JG; Griffin WS
Mol Psychiatry; 1999 Jan; 4(1):39-45. PubMed ID: 10089007
[TBL] [Abstract][Full Text] [Related]
5. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity.
Glantz LA; Lewis DA
Arch Gen Psychiatry; 1997 Jul; 54(7):660-9. PubMed ID: 9236550
[TBL] [Abstract][Full Text] [Related]
6. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia.
Hashimoto T; Volk DW; Eggan SM; Mirnics K; Pierri JN; Sun Z; Sampson AR; Lewis DA
J Neurosci; 2003 Jul; 23(15):6315-26. PubMed ID: 12867516
[TBL] [Abstract][Full Text] [Related]
7. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity.
Glantz LA; Lewis DA
Arch Gen Psychiatry; 1997 Oct; 54(10):943-52. PubMed ID: 9337775
[TBL] [Abstract][Full Text] [Related]
8. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia.
Volk DW; Austin MC; Pierri JN; Sampson AR; Lewis DA
Arch Gen Psychiatry; 2000 Mar; 57(3):237-45. PubMed ID: 10711910
[TBL] [Abstract][Full Text] [Related]
9. Decreased reelin expression in the left prefrontal cortex (BA9) in chronic schizophrenia patients.
Habl G; Schmitt A; Zink M; von Wilmsdorff M; Yeganeh-Doost P; Jatzko A; Schneider-Axmann T; Bauer M; Falkai P
Neuropsychobiology; 2012; 66(1):57-62. PubMed ID: 22797278
[TBL] [Abstract][Full Text] [Related]
10. Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia.
Eastwood SL; Burnet PW; Harrison PJ
Neuroscience; 1995 May; 66(2):309-19. PubMed ID: 7477874
[TBL] [Abstract][Full Text] [Related]
11. MRNA expression patterns and distribution of white matter neurons in dorsolateral prefrontal cortex of depressed patients differ from those in schizophrenia patients.
Molnar M; Potkin SG; Bunney WE; Jones EG
Biol Psychiatry; 2003 Jan; 53(1):39-47. PubMed ID: 12513943
[TBL] [Abstract][Full Text] [Related]
12. Cellular basis of reduced cortical reelin expression in schizophrenia.
Eastwood SL; Harrison PJ
Am J Psychiatry; 2006 Mar; 163(3):540-2. PubMed ID: 16513881
[TBL] [Abstract][Full Text] [Related]
13. α7 nicotinic receptor agonism mitigates phencyclidine-induced changes in synaptophysin and Arc gene expression in the mouse prefrontal cortex.
Thomsen MS; Hansen HH; Mikkelsen JD
Neurochem Int; 2010 Dec; 57(7):756-61. PubMed ID: 20817066
[TBL] [Abstract][Full Text] [Related]
14. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.
Akbarian S; Kim JJ; Potkin SG; Hagman JO; Tafazzoli A; Bunney WE; Jones EG
Arch Gen Psychiatry; 1995 Apr; 52(4):258-66. PubMed ID: 7702443
[TBL] [Abstract][Full Text] [Related]
15. Detection and quantification of hippocampal synaptophysin messenger RNA in schizophrenia using autoclaved, formalin-fixed, paraffin wax-embedded sections.
Eastwood SL; Harrison PJ
Neuroscience; 1999; 93(1):99-106. PubMed ID: 10430474
[TBL] [Abstract][Full Text] [Related]
16. Increased levels of SNAP-25 and synaptophysin in the dorsolateral prefrontal cortex in bipolar I disorder.
Scarr E; Gray L; Keriakous D; Robinson PJ; Dean B
Bipolar Disord; 2006 Apr; 8(2):133-43. PubMed ID: 16542183
[TBL] [Abstract][Full Text] [Related]
17. Regulator of G-protein signalling 4 expression is not altered in the prefrontal cortex in schizophrenia.
Stuart Gibbons A; Scarr E; McOmish CE; Hannan AJ; Thomas EA; Dean B
Aust N Z J Psychiatry; 2008 Aug; 42(8):740-5. PubMed ID: 18622782
[TBL] [Abstract][Full Text] [Related]
18. GABAA receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls.
Akbarian S; Huntsman MM; Kim JJ; Tafazzoli A; Potkin SG; Bunney WE; Jones EG
Cereb Cortex; 1995; 5(6):550-60. PubMed ID: 8590827
[TBL] [Abstract][Full Text] [Related]
19. Synaptophysin gene expression in schizophrenia. Investigation of synaptic pathology in the cerebral cortex.
Eastwood SL; Cairns NJ; Harrison PJ
Br J Psychiatry; 2000 Mar; 176():236-42. PubMed ID: 10755070
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of GABAA receptor binding on neurons of the prefrontal cortex in schizophrenic subjects.
Benes FM; Vincent SL; Marie A; Khan Y
Neuroscience; 1996 Dec; 75(4):1021-31. PubMed ID: 8938738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
